Showing results (41-50 of 168) with videos related to
Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry|December 19, 2008
Studies on anti-HIV quinolones: new insights on the C-6 positionSerena Massari, Dirk Daelemans, Giuseppe Manfroni, et al.RSC Medicinal Chemistry|May 12, 2025
Biological assessments of novel ultrasound-synthesized 2-arylbenzimidazole derivatives: antiproliferative and antibacterial effectsIvana Sokol, Anja Rakas, Dajana Kučić Grgić, et al.Chemmedchem|November 22, 2017
Synthesis and Biological Evaluation of Pyrrolo[2,1-f][1,2,4]triazine C-Nucleosides with a Ribose, 2'-Deoxyribose, and 2',3'-Dideoxyribose Sugar MoietyQingfeng Li, Eveline Lescrinier, Elisabetta Groaz, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 1, 2020
enAsCas12a Enables CRISPR-Directed Evolution to Screen for Functional Drug Resistance Mutations in Sequences Inaccessible to SpCas9Jasper Edgar Neggers, Maarten Jacquemyn, Tim Dierckx, et al.Bioorganic Chemistry|November 29, 2024
Synthesis of novel imino-coumarin and acrylonitrile 2-benzazole hybrids as potent anticancer agents targeting tubulinIda Boček Pavlinac, Leentje Persoons, Anja Beč, et al.Biomedicines|May 28, 2022
Cellular Stress Induces Nucleocytoplasmic Transport Deficits Independent of Stress GranulesJoni Vanneste, Thomas Vercruysse, Steven Boeynaems, et al.Antiviral Research|December 3, 2014
A stably expressed llama single-domain intrabody targeting Rev displays broad-spectrum anti-HIV activityEline Boons, Guangdi Li, Els Vanstreels, et al.Chemical Biology & Drug Design|September 9, 2015
Design, Synthesis, and Biological Evaluation of Novel 2-(Pyridin-3-yloxy)acetamide Derivatives as Potential Anti-HIV-1 AgentsBoshi Huang, Xiao Li, Peng Zhan, et al.Antiviral Research|June 11, 2009
Capture and transmission of HIV-1 by the C-type lectin L-SIGN (DC-SIGNR) is inhibited by carbohydrate-binding agents and polyanionsJoeri Auwerx, Katrien O François, Els Vanstreels, et al.European Journal of Medicinal Chemistry|November 20, 2012
Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitorsSergio R Ribone, Volker Leen, Marcela Madrid, et al.Pageof 17